You are here

Exicure

AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure

Fierce Biotech

Wed, 12/14/22 - 10:44 am

BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives

BioSpace

Fri, 10/7/22 - 10:45 am

Bristol Myers Squibb

Rubius Therapeutics

Finch Therapeutics

In survival mode, Exicure cuts to the bone — pausing all R&D and chopping headcount by 66%

Endpoints

Tue, 09/27/22 - 10:25 am

Ipsen forges $1bn alliance with Exicure on neurodegenerative diseases

Pharmaforum

Mon, 08/2/21 - 10:54 am

neurodegenerative disease

Exicure Announces Positive Phase Ib Trial Results for Solid Tumor Treatment

BioSpace

Thu, 09/17/20 - 11:01 pm

clinical trials

Allergan enlists Exicure in search of hair loss drugs with $25M upfront, doubling down on area dear to AbbVie

Endpoints

Thu, 11/14/19 - 10:29 am

Purdue Pharma Puts Skin In The Game With Psoriasis Deal

Seeking Alpha

Thu, 12/15/16 - 10:09 am